Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE.
Why this new battery alliance matters for Arkema stock
Arkema (ENXTPA:AKE) has just signed a Memorandum of Understanding with Senior to work more closely across the battery value chain, focusing on materials, separator films and manufacturing techniques for next generation cells.
The move, combined with Arkema's recent EcoVadis Gold Medal for sustainability, gives investors fresh information on how the group is positioning its specialty materials portfolio in electric mobility and energy storage.
See our latest analysis for Arkema.
Despite the new battery partnership and recent sustainability recognition, Arkema's 1 year total shareholder return of 27.76% and 5 year total shareholder return of 30.64% sit in contrast to a recent 90 day share price return of 4.18%. This suggests only a tentative pickup in short term momentum.
If this battery push has you thinking about where else materials and mobility trends might show up, it could be worth scanning auto manufacturers for other ideas tied to the transition in transport.
Arkema's shares have lagged over 1 and 5 years, even as its battery ambitions, €9.2b revenue base and EcoVadis Gold Medal gain attention. Is the current valuation still underappreciating its prospects, or is this already reflected in the share price?
Most Popular Narrative: 21% Undervalued
Arkema's most followed narrative puts fair value at €65.06 versus a last close of €51.40, framing the battery alliance inside a broader specialty materials repositioning.
The company's sustained emphasis on R&D and innovation (especially in differentiated materials for batteries, 3D printing, bio-based polymers, and advanced electronics) enhances Arkema's ability to introduce high-value, eco-friendly products that can command premium pricing, supporting long-term revenue growth and gross margin expansion.
Curious what earnings path and margin rebuild need to play out for that fair value to hold up. The narrative leans heavily on faster profit growth than sales. It also assumes a future valuation multiple that looks different to where the shares sit today. Want to see how those pieces fit together.
Result: Fair Value of €65.06 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, those assumptions could be knocked off course if cyclical end markets like construction stay weak, or if competition and overcapacity keep pressure on acrylics margins.
Find out about the key risks to this Arkema narrative.
Build Your Own Arkema Narrative
If you see the story differently or prefer to test the assumptions yourself, you can build a fresh view in a few minutes with Do it your way .
A great starting point for your Arkema research is our analysis highlighting 2 key rewards and 3 important warning signs that could impact your investment decision.
Looking for more investment ideas?
If Arkema has caught your eye, do not stop there. Put a few minutes into fresh ideas so you are not leaving potential opportunities on the table.
-
Spot potential value by scanning these 871 undervalued stocks based on cash flows that line up with what you want to pay for future cash flows.
-
Tap into fast moving themes by checking out these 24 AI penny stocks riding the growth in artificial intelligence and automation.
-
Build a cash focused watchlist by reviewing 3%","yLinkElement":"context_link","yModuleName":"content-canvas","yTrafficOrigin":"content-canvas default"}" rel="noopener noreferrer nofollow">these 13 dividend stocks with yields > 3% for companies offering yields above 3%.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include AKE.PA .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
